NEW YORK (GenomeWeb News) — Affymetrix is launching a program to fund microarray-related cancer research at European research centers, the company said today.
 
Under the Collaborations in Cancer Research Program, Affymetrix said it will financially support “selected research projects” that use a variety of microarray-based applications and that are aimed at developing new understanding and discoveries in 10 types of cancer.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The apple has traveled westward and eastward along the Silk Road, according to a new genetic analysis.

In Nature this week: GWAS data used to reposition drugs for psychiatric use, and more.

Genetic disease risk information doesn't always spur people to make healthy lifestyle changes, according to the Associated Press.

A University of California, San Diego-led team has used liquid biopsies to uncover possible treatments for patients with cancers of unknown primary.